You searched for "infections"
Thalamic infarcts and the associated neuro-ophthalmic sequelae
3 June 2021
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The authors present a retrospective review of clinical and imaging data from a stroke database over a 10-year period. Of those identified as having a thalamic infarction (n=342), 40 were found to have neuro-ophthalmic sequelae (11.7%). The neuro-ophthalmic sequelae reported...
Is patient masking leading to an increase in post-op infection after eyelid surgery?
21 October 2020
| Marion Sikuade, Jennifer HY Tan, Zanna Currie
|
EYE - Oculoplastic
Due to the COVID-19 pandemic, the use of facemasks or face coverings in the clinical setting has become necessary. It is important to recognise that facemasks can be a source of infection after eye surgery and consider ways to minimise...
Review of paediatric infectious endophthalmitis
This paper presents a review on paediatric infectious endophthalmitis and considers aetiology, prognosis and management. Classification included exogenous and endogenous. Diagnosis was based on presenting history, signs and symptoms, cultures and imaging. Exogenous cases included postoperative endophthalmitis (strabismus surgery, glaucoma...Intravitreal injections delivered by ophthalmic clinical nurse specialists
1 June 2015
| Rita McLauchlan, D Armstrong, Konstantinos Balaskas, Sajjad Mahmood
|
EYE - Vitreo-Retinal
Intravitreal injections of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab, for the treatment of wet age-related macular degeneration (AMD) was approved by National Institute for Health & Care Excellence (NICE) in 2008 [1]. The Manchester Royal Eye Hospital (MREH),...
The role of injection assistant devices in establishing a nurse-led AMD service
1 April 2018
| Hani Hasan
|
EYE - Vitreo-Retinal
The author shares his experience of setting up a nurse-led service to deliver anti-VEGF intravitreal injections and how injection assistant devices supported training. Age-related macular degeneration (AMD) has become a leading cause of irreversible blindness [1]. It is estimated that...
PACK-crosslinking for infectious keratitis
1 October 2015
| David Tabibian, Farhad Hafezi
|
EYE - Cornea
Corneal cross-linking with riboflavin and UV-A light (CXL) is a technology that has been initially developed to treat corneal ectatic disorders [1]. Its effect in stabilising diseases such as keratoconus was reported in numerous trials with excellent long-term outcomes and...
Culture positivity of needles for IVT injections
1 December 2013
| Saruban Pasu
|
EYE - Vitreo-Retinal
Given the worldwide use of intravitreal (IVT) injections, the authors of this paper set out to evaluate the rate of culture positivity of the needles used in routine IVT injections and compare this positivity between 27-gauge and 30-gauge needle tips....
Internuclear ophthalmoplegia: a case study
3 June 2024
| Miguel Kurc
|
EYE - General
A 44-year-old patient presents with binocular, mostly horizontal diplopia when fixating on moving objects. This has been ongoing for approximately five years. He is known to have multiple sclerosis and had an episode of optic neuritis six years prior in...
Short-term outcome after intravitreal ranibizumab injections for ROP
1 December 2013
| Jonathan Chan
|
EYE - Vitreo-Retinal
This is an interventional case series study of three premature babies (six eyes) with high risk prethreshold or threshold retinopathy of prematurity (ROP) with plus disease that received intravitreal ranibizumab injections for ROP. All infants received intravitreal ranibizumab injections of...
2018 update on intravitreal injections
1 December 2018
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this review article the authors have highlighted the standardised and structured approach to intravitreal injections (IVI) by examining the recent evidence-based literature. IVI is the most commonly performed procedure worldwide with low potential risk of endophthalmitis. IOP spikes are...
Can intravitreal anti-VEGF injections affect corneal nerves?
This was a retrospective case-control study looking at the effect of anti-VEGF injections on corneal nerves (CN). Fifty-seven patients with a history of at least three anti-VEGF injections in one or both eyes and available confocal microscopic imaging were included...
Ozurdex use in noninfectious uveitis
1 June 2016
| Saruban Pasu
|
EYE - Vitreo-Retinal
Burkholder et al. reported the practice patterns of 45 respondents of approximately 176 surveyed members of the American Uveitis Society regarding the use of the Ozurdex implant. Most respondents performed the injection in either a procedure (41.0%) or clinic (23.1%)...
